Real-World Outcomes in Non-metastatic Non-small Cell Lung Cancer (NSCLC): An I-O Optimise MultiCountry Analysis

被引：0

作者：

Daumont, M. J. ^{[1
]}

Rault, C. ^{[2
]}

Baltus, H. ^{[3
]}

Ding, P. Q. ^{[4
]}

Emanuel, G. ^{[5
]}

Lucherini, S. ^{[5
]}

Vo, L. ^{[6
]}

Greystoke, A. ^{[7
]}

Katalinic, A. ^{[3
]}

Leal, C. ^{[8
]}

Muwaffak, M. ^{[9
]}

Oskarsdottir, G. N. ^{[10
,11
]}

Waldmann, A. ^{[3
]}

Wagenius, G. ^{[12
,13
]}

Cheung, W. Y. ^{[4
]}

Munro, R.

Schoemaker, M. J. ^{[14
]}

机构：

[1] Bristol Myers Squibb, Braine Lalleud, Belgium

[2] Data Gnosis, Rennes, France

[3] Univ Lubeck, Lubeck, Germany

[4] Oncol Outcomes O2, Calgary, AB, Canada

[5] Bristol Myers Squibb, Uxbridge, Middx, England

[6] Bristol Myers Squibb, Princeton, NJ USA

[7] Newcastle Hosp & Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England

[8] IQVIA, Porto, Portugal

[9] IQVIA, London, England

[10] Skane Univ Hosp, Lund, Sweden

[11] Lund Univ, Lund, Sweden

[12] Karolinska Inst, Stockholm, Sweden

[13] Karolinska Univ Hosp, Stockholm, Sweden

[14] IQVIA, Amsterdam, Netherlands

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

non-metastatic non-small cell lung cancer; real-world; survival;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.25-05

引用

页码：S269 / S270

页数：2